About the Authors

Kimberly Mattia

Contributed equally to this work with: Kimberly Mattia, Bridget A. Puffer

Affiliation Integral Molecular, Inc., Philadelphia, Pennsylvania, United States of America

Bridget A. Puffer

Contributed equally to this work with: Kimberly Mattia, Bridget A. Puffer

Affiliation Integral Molecular, Inc., Philadelphia, Pennsylvania, United States of America

Katherine L. Williams

Affiliation Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, California, United States of America

Ritela Gonzalez

Affiliation Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, California, United States of America

Meredith Murray

Affiliation Integral Molecular, Inc., Philadelphia, Pennsylvania, United States of America

Emily Sluzas

Affiliation Integral Molecular, Inc., Philadelphia, Pennsylvania, United States of America

Dan Pagano

Affiliation Integral Molecular, Inc., Philadelphia, Pennsylvania, United States of America

Sandya Ajith

Affiliation Integral Molecular, Inc., Philadelphia, Pennsylvania, United States of America

Megan Bower

Affiliation Integral Molecular, Inc., Philadelphia, Pennsylvania, United States of America

Eli Berdougo

Affiliation Integral Molecular, Inc., Philadelphia, Pennsylvania, United States of America

Eva Harris

Affiliation Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, California, United States of America

Benjamin J. Doranz

bdoranz@integralmolecular.com

Affiliation Integral Molecular, Inc., Philadelphia, Pennsylvania, United States of America

Competing Interests

The authors have read the journal's policy and have the following conflicts. Integral Molecular, Inc. offers Dengue Reporter Virus Particles as a commercial product and has filed a patent (Patent Application # 12/942632) that describes how Dengue RVPs are made. KM, BP, MM, ES, DP, SA, MB, EB, and BJD are all employees of Integral Molecular. BJD is a shareholder of Integral Molecular. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: KM BAP KLW EH BJD. Performed the experiments: KM BAP KLW RG MM ES DP SA MB. Analyzed the data: KM BAP KLW EB EH BJD. Wrote the paper: KM BAP KLW EB EH BJD.